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Abstract
The successful integration of in vitro-generated tissues is dependent on adequate vascularization
in vivo. Human outgrowth endothelial cells (OECs) isolated from the mononuclear cell fraction of
peripheral blood represent a potent population of circulating endothelial progenitors that could
provide a cell source for rapid anastomosis and scaffold vascularization. Our previous work with
these cells in co-culture with primary human osteoblasts has demonstrated their potential to
form perfused vascular structures within a starch–poly(caprolactone) biomaterial in vivo. In the
present study, we demonstrate the ability of OECs to form perfused vascular structures as early
as 48 h following subcutaneous implantation of the biomaterial in vivo. The number of OEC-
derived vessels increased throughout the study, an effect that was independent of the OEC donor.
This finding of rapid and thorough OEC-mediated scaffold vascularization demonstrates the great
potential for OEC-based strategies to promote vascularization in tissue engineering. OECs have
the potential to contribute to host-derived scaffold vascularization, and formed vascular structures
at a similar density as those arising from the host. Additionally, immunohistochemical evidence
demonstrated the close interaction between OECs and the co-cultured osteoblasts. In addition to
the known paracrine activity osteoblasts have in modulating angiogenesis of co-cultured OECs, we
demonstrate the potential of osteoblasts to provide additional structural support for OEC-derived
vessels, perhaps acting in a pericyte-like role. Copyright  2010 John Wiley & Sons, Ltd.
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1. Introduction
Appropriate in vivo vascularization is paramount to
the therapeutic success of in vitro-engineered tissue
constructs. Outgrowth endothelial cells (OECs) represent
*Correspondence to: Shahram Ghanaati, Institute of Pathology,
Langenbeckstrasse 1, Johannes Gutenberg University, 55101
Mainz, Germany. E-mail: ghanaati@uni-mainz.de
# These authors contributed equally to this study.
a potentially potent population of endothelial progenitor
cells that can be isolated in cultures of mononuclear
cells from human peripheral blood and can be used in
complex tissue engineering strategies to enhance scaffold
vascularization (Fuchs et al., 2006a, 2006b, 2009a; Au
et al., 2008; Melero-Martin et al., 2007; Silva et al.,
2008). The ability of OECs and other endothelial cells
to form vessel-like structures has been demonstrated by
our group in vitro in mono- and co-culture methods in
both two- and three-dimensional (2D and 3D) cultures
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(Fuchs et al., 2006a; Unger et al., 2004, 2005; Fuchs
et al., 2007, 2009b. A recent study by our group found
that, in co-culture with human primary osteoblasts (pOB)
on starch–poly(caprolactone) fibre meshes (SPCL), OECs
significantly contributed to in vivo scaffold vascularization
by forming fully perfused vessels following implantation
(Fuchs et al., 2009c). The contribution of the pOB
component of the co-culture is crucial, as OECs seeded
alone on SPCL did not demonstrate the same potency
to form vascular structures in vivo in this study. Similar
observations have been found for primary endothelial
cells in co-culture with osteoblasts in vivo (Unger et al.,
2007, 2010). In these previous studies, we have suggested
that the pOBs play a role in endothelial cell-derived vessel
formation through the production of extracellular matrix
and the secretion of pro-angiogenic signalling molecules,
resulting in vessel-like formation in vitro (Fuchs et al.,
2007; Santos et al., 2009). Accordingly, osteoblasts have
been viewed as a natural source for potent signalling
molecules that modulate the angiogenic behaviour of the
co-cultured endothelial cells, suggesting the existence of a
natural synergy between osteoblasts and endothelial cells.
This phenomenon of enhanced vessel formation arising
from precultured endothelial cells when in co-culture
with osteoblasts could be used as a strategy for complex
tissue engineering, where scaffold vascularization and
rapid integration are essential for survival of the cell-
seeded construct. The use of osteoblasts in the co-culture
could be especially suited for tissue engineering of bone,
where the osteoblasts could contribute to the functional
vascularization that is required for bone regeneration,
while also perhaps providing bone-specific functionality.
In this study, we evaluated the time course necessary
for in vitro-generated OEC–pOB co-cultures to form func-
tional vessels anastomosed with host vasculature in vivo.
Our previous reports on this phenomenon used only end-
point identification of OEC-derived vascular structures
and indicated a contribution to this process when OECs
were co-cultured with pOBs (Fuchs et al., 2009c)[11]. In
the present study we performed a dynamic immunohisto-
logical study at multiple time points to determine when
in vitro-generated OEC–pOB constructs first demonstrate
anastomosis with host vasculature in vivo to form perfused
vascular structures (’inosculation’) within the construct.
We also use immunohistological staining to determine
whether the OEC and pOB cells interact following trans-
plantation of the construct in vivo, with a view to elu-
cidating the role pOBs play in OEC-mediated scaffold
vascularization by determining whether osteoblasts struc-
turally contribute to vascularization in addition to their
previously demonstrated paracrine contribution.
2. Materials and methods
2.1. Isolation of human OECs
Outgrowth endothelial cells (OECs) were isolated accord-
ing to previously established methods (Fuchs et al., 2006a,
2006b, 2007, 2009c). In brief, mononuclear cells were
isolated from human peripheral blood buffy coats by
Ficoll (Sigma-Aldrich)-gradient centrifugation and cul-
tured in endothelial cell growth medium-2 (EGM-2;
Lonza) complete with 5% fetal calf serum (FCS; Gibco
Life Technologies) and 1% penicillin–streptomycin. Cells
were cultured on collagen-coated 24-well plates (BD
Europe) at 5 × 106 cells/well. Single colonies of OECs,
appearing with endothelial morphology after 3–4 weeks
in culture, were trypsinized and expanded during sev-
eral passages in a splitting ratio of 1 : 2 or 1 : 3. OECs
from two donors were used in this study. The endothelial
phenotype of these cells was stable in long-term culture,
assessed previously using RT–PCR, immunofluorescence,
flow cytometry and angiogenesis assays.
2.2. Isolation of human osteoblasts
Bone fragments were derived from consenting patients
undergoing orthopaedic or trauma surgery procedures.
This was approved by the responsible ethical committee.
Primary osteoblasts were isolated and cultured according
to an outgrowth protocol, as previously described (Fuchs
et al., 2009c; Hofmann et al., 2003). In brief, bone
fragments were minced and rinsed several time in
phosphate-buffered saline (PBS), after which the bone
tissue was digested by collagenase (Type IV C-5138,
Sigma, Deisenhofen, Germany) for 1 h at 37 ◦C. After
this digestion step, the bone fragments were again
rinsed several times with PBS. The bone fragments were
incubated in DMEM/Hams F12 (Gibco) supplemented
with 20% FCS and 1% penicillin–streptomycin to foster
outgrowth of the cells from the bone fragments. Confluent
cultures were passaged 1 : 3 using acutase (PAA) and
further cultured in DMEM/Hams F12 including 10% FCS.
2.3. Generation of SPCL co-culture constructs
SPCL scaffolds were generated and sterilized as previously
described (Gomes et al., 2003). Prior to cell seeding,
the scaffolds were coated with fibronectin according
to standard protocols (Santos et al., 2007). SPCL was
seeded with 250 000 primary osteoblasts and 250 000
OECs for the co-cultures. The same cell culture medium,
EGM-2 with 5% FCS, was used for co-cultures according
to a previously established protocol, without additional
supplementation with angiogenic growth factors (Fuchs
et al., 2007). The cells were cultured in vitro for a total of
7 days prior to implantation. OECs from each of the two
donors individually were used to generate constructs.
2.4. In vivo assessment of SPCL co-cultures
The Committee on the Use of Live Animals in Teaching
and Research, Rheinland-Pfalz, Germany, approved
this animal protocol. Twenty 6 week-old male SCID
mice (Charles River Laboratories) were housed under
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standard conditions and provided with water ad libitum,
artificial light and normal mouse pellets (Laboratory
Rodent Chow, Altromin) at the Laboratory Animal Unit,
Johannes Gutenberg University, Mainz, Germany. The
in vitro-generated SPCL constructs were embedded in
400 µl Matrigel before implantation. After gelation the
constructs were implanted in preformed subcutaneous
pockets of the subscapular region, as described previously
(Fuchs et al., 2009c; Ghanaati et al., 2010). Briefly, the
shaved skin of the rostral portion of the interscapular
region was incised and the biomaterial was placed into
a subcutaneous pocket under the thin skin muscle of the
animal. The wound was subsequently stitched with 6.0
Prolene (Ethicon). Each surgical procedure was carried
out under strictly aseptic conditions and care was taken
to close the operation site immediately after biomaterial
implantation, with incisions being accurately stitched. All
animals survived the operation procedure and in all cases
the implantation site healed without complications. In
total, 10 animals received SPCL co-cultures with OECs
from donor 1 and 10 animals received scaffolds with
OECs from donor 2. Additionally, two constructs from
each OEC donor were processed for histology at the time
of implantation (time zero controls). Two animals from
each donor subgroup were sacrificed with an overdose of
ketamine and xylazine at days 2, 5, 8, 11 and 14 following
implantation, in order to conduct a dynamic study on the
transformation of the cell constructs in vivo.
2.5. Histological preparation
Immediately after death, the implants of all groups were
explanted together with the surrounding peri-implant
tissue and fixed in 4% formalin for 24 h for further
histological and immunohistochemical analysis. The
implant site of each animal was cut into three segments to
include the SPCL constructs. After fixation, the segments
were dehydrated in a series of alcohols, transferred to
xylene and embedded in paraffin. Serial 3–4 µm thick
paraffin sections were prepared from the central section,
deparaffinized and rehydrated. Endogenous peroxidase
activity was quenched by treatment with 3% H2O2
in demineralized water. After blocking with serum-free
Protein Block (Dako), the sections were stained with
haematoxylin and eosin (H&E) and immunohistologically
stained for specific endothelial and osteogenic markers.
To identify OECs, one section was stained with a mouse
antibody against human-specific von Willebrand factor
(vWF) or CD 31 (PECAM) (Dako). To identify all human-
derived cells within the implantation bed, a section was
stained with a rabbit antibody to vimentin (Dako). The
use of serial sections of CD 31 and vimentin enabled
the detection of osteoblasts within the implantation bed,
since these cells were vimentin-positive and CD 31-
negative. OECs stained positive for both markers. After
incubation with primary antibodies, the Dako REAL
En Vision Detection System, Peroxidase/DAB+, mouse-
anti-rabbit (Dako) was used, which visualizes the reaction
with diaminobenzidine. As negative control for each of
the above stainings performed, one section was treated
similarly without adding any primary antibody. All control
stains were negative. Isolectin B4 (Vector Laboratories)
was used to stain murine endothelial cells, which were
then visualized with diaminobenzidine.
OEC-derived vessels were detectable by staining for
human-specific von Willebrand factor as well as human-
specific CD31. For the results shown here, only CD31 is
shown. Murine vessels were detectable by isolectin B4 and
were distinguishable from human-specific OEC-derived
vessels. These isolectin-stained sections were used for
quantification of host-mediated scaffold vascularization,
but no murine-specific staining is shown in the figures.
Previous reports have demonstrated the detection of OEC-
derived and murine-derived vessels at day 14 after implan-
tation using human-specific vWF and isolectin B4, respec-
tively (Fuch et al., 2009c). This report focuses primarily on
the OEC-derived microvessels and exemplifies this using
CD31 staining, although vWF and isolectin stainings were
also performed for verification and quantification.
2.6. Histomorphometric analysis
of vascularization
Histomorphometric analysis was performed using the
software NIS-Elements (Nikon) according to the man-
ufacturer’s instructions and following a protocol that
we had previously established (Ghanaati et al., 2009).
Briefly, images were obtained with a DS-Fi1/digital cam-
era connected to an Eclipse 80i histological microscope
(Nikon), which was equipped with an automatic scanning
table (Prior). A total scan, one large image assembled
from 100–120 images of the region of interest contain-
ing the biomaterial and the corresponding peri-implant
tissue was taken by using a ×100 magnification at a
resolution of 2500 × 1200 pixels. For each animal, two
consecutive slides that were stained with vWF or CD31
antibody were used to detect the OEC-derived vessels
and an additional two sections stained with isolectin B4
were used to detect murine-derived vasculature. Using
the NIS-Elements ‘annotations and measurements’ tool,
the total biomaterial area was measured and human-
derived (OEC) and murine-derived (host) vessels were
marked separately. Human cell-lined capillaries contain-
ing intraluminal erythrocytes were quantified as vessels
having undergone anastomosis and considered to be func-
tional vasculature in vivo. The total number of each type
of vessel was quantified for each slide. The planar density
of specific vessels was determined from the total number
of each type of vessel divided by the total biomaterial
area in mm2, providing a measure of density in terms of
vessels/mm2. The total scaffold vascularization (human-
and murine-derived) was determined by summing the
totals for each of the specific cell types. For each time
point, a mean number of vessels/mm2 was determined for
each donor, with n = 2 animals per time point per donor.
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Figure 1. Immunohistochemical staining for human endothelial marker CD31 in OEC–pOB co-cultures at the time of implantation
(time zero control) (A), with arrows indicating sprout-like structures. Implantation time points of 2 (B), 5 (C), 8 (D), 11 (E) and
14 (F) days are also shown. At all post-implantation time points there was evidence of perfused vascular structures. Magnification
= ×400 (A, D) and ×600 (B, C, E, F); all scale bars = 100 µm
3. Results
Human-specific immunohistochemical detection of OECs
following 7 days of in vitro co-culture with pOB and
immediately prior to implantation (time zero control)
demonstrated the presence of a connective tissue-like
formation between the fibres of the SPCL mesh
(Figure 1A). The CD31-positive staining of this pre-
implantation sample revealed the formation of sprout-
and vessel-like structures on the surface of the SPCL
(Figure 1A, arrows). After 2 days of implantation in vivo,
there was already some evidence of human-specific vessel
structures within the mesh of the material bed in close
proximity to the murine vessels (Figure 1B). These vessels
were already anastomosed with the host vascular network
at day 2, as indicated by visible erythrocytes within the
lumen of these human-specific vessels (Figure 1B). During
days 2–14 the number of OEC-derived microvessels
increased, as did the number that showed evidence of
perfusion with murine erythrocytes (Figure 1C–F). At the
end of the observational period, following 14 days of
implantation, the SPCL constructs were homogenously
vascularized by both OEC- and murine-derived vessels.
Histomorphometric analysis of the density of OEC-
derived human vessels within the implantation bed was
performed from a total scan of a histological slide
of the implantation bed that was stained with an
antibody to human-specific CD31 (Figure 2). In total,
n = 2 animals/donor/time point were used. At day 2
after implantation, there were already 2.7 (±0.6) and
4.0 (±0.7) OEC-derived vessels/mm2 for donors 1 and
2, respectively. This number continued to increase, and
by day 14 there were 11.4 (±1.8) and 17.8 (±0.8)
OEC-derived vessels/mm2, for OECs from each of the
two donors. Regardless of donor, the trend was for
an increase in OEC-derived vascular structures over
the implantation time. Quantification of vascularization
arising from murine endothelial cells demonstrated
similar trends (Figure 2). By day 14 of implantation,
there were a total of 13.8 (±3.8) and 11.9 (±1.9)
murine vessels/mm2 for constructs from each of the
two OEC donors, respectively. The rate of vascularization
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Figure 2. Histomorphometric quantification of total blood
vessels (black), the sum of which derives from human OECs
(red) and murine endothelial cells (blue) for donor 1 (A) and
donor 2 (B). Vessel number is expressed per scaffold area at
various times post-implantation and n = 2 per time point per
donor
and number of vascular structures was similar for both
human- and murine-derived vessels. By the end of the
study, vascularization arising from OECs accounted for
44.9% and 60.0% of total scaffold vascularization for
donors 1 and 2, respectively. This indicates a substantial
functional contribution of the precultured OECs towards
overall scaffold vascularization.
Histological results from the various in vivo time
points showed no sign of bone-specific matrix formation,
either on the surface of the SPCL material or within
the implantation bed. However, immunohistochemical
detection of osteoblasts by means of serial vimentin-
and CD 31-stained sections demonstrated that the
pOB cells from the co-culture remained present and
viable throughout the study, and were embedded in an
extracellular matrix (Figure 3A, B). Moreover, staining
consecutive sections (Figure 3A, C and B, D) with
vimentin (Figure 3A, B) and CD 31 (Figure 3C, D)
revealed co-localization of pOBs and OECs both at the
scaffold surface and within the SPCL fibres. These pOBs
surrounded the OEC-lined vessel, serving what appeared
to be a type of pericyte-like function in supporting these
OEC-derived vessels.
4. Discussion
The potential of human outgrowth endothelial cells
to contribute to vascularization in complex tissue-
engineering strategies has been established by our group
and others (Fuchs et al., 2006a, 2009a). Additionally, we
have demonstrated potential for mature endothelial cells
derived from human dermal tissue to act in a similar
capacity (Unger et al., 2004, 2005, 2007). Observations
with both OECs and other primary endothelial cells,
originally demonstrated in vitro, have also been verified
in vivo (Fuchs et al., 2009c; Unger et al., 2010). In one
such study, we found co-cultures of OEC and pOB on
SPCL scaffolds to have a high potency for the formation
of human-specific vascular structures when transplanted
in vivo (Fuchs et al., 2009c). This study, which focused
on a single histological endpoint, indicated both the
formation of OEC-derived vessels and a contribution to
this phenomenon from the osteoblast component, acting
as a natural source for potent angiogenic signalling within
the co-culture. However, further mechanisms regarding
the time course of the OEC-derived vessel formation
in vivo and the further potential roles of osteoblasts were
not completely elucidated. In the present study, we have
examined the formation of these OEC-derived vessels in
a more dynamic approach, with several histological time
points and total implant histomorphometric analysis at
each time point, in order to determine the time course of
OEC-derived vessel formation along with the dynamics of
total scaffold vascularization by both OEC- and murine-
derived vessels. Additionally, we have used vimentin
human-specific staining, which was not performed in our
previous study, coupled with CD 31 staining to specifically
detect pOBs within the co-culture, in order to determine
the specific location and potential contribution of these
cells to OEC-derived vessel formation.
In this investigation, along with previous studies by
our group (Fuchs et al., 2007), it is apparent that
even prior to implantation, the OEC component was
primed for the formation of vascular structures. The
bud- or sprout-like structures seen in the histology of
these scaffolds, following in vitro co-culture but prior
to implantation, are reminiscent of the first stages of
angiogenesis, where endothelial cells begin to reorganize
and form sprouts that eventually lead to new vessels
(Carmeliet, 2005; Folkman, 2003). Following 2 days of
implantation, there was evidence of OEC-specific vessels
with apparent lumena. The presence of erythrocytes
within these lumena indicates that some human-derived
vascular structures were already anastomosed to the
host blood supply and were functionally contributing to
vascularization of the implantation bed after only 48 h
in vivo. These findings indicate the potential of OECs to
form microvessel-like structures during in vitro cultivation
that enable rapid anastomoses upon implantation,
suggesting this as a potential ‘natural’ anastomosis
technique for tissue engineering. Histomorphometric
quantification of human-specific vessels demonstrated
that the number of perfused human-derived vascular
structures increased approximately four-fold from day
2 to day 14 of implantation. Although there appeared to
be some differences in cell potency between the two OEC
donor sources, both donors demonstrated an increase in
human-derived vascularization of the scaffold over the
evaluation period. One of the main differences between
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Figure 3. Immunohistochemical staining for vimentin (left), which specifically stains human cells within the implantation bed (both
osteoblasts and OEC-derived endothelial cells), along with staining of the serial histological sections with an antibody specific to
human CD31 (right) to visualize only OEC-derived endothelial cells. Serial sections (A, C) and (B, D) indicate the co-localization
of pOBs and OECs, with the pOBs immediately surrounding the OEC vessel structures. Red arrows, OEC-derived endothelial cells;
blue arrows, human osteoblasts; green arrows, murine-derived cells, which are negative for both stains. Magnification = ×600 for
all images; scale bars = 100 µm
the two donors (Figure 2) is that in one the principal
acceleration of vessel growth took place between days
2 and 5, whereas in the other donor this took place
later, that is, between days 5 and 8. Moreover, the OEC-
derived vessels made a substantial contribution to overall
scaffold vascularization, as the number of vessels arising
from OECs was similar to the number arising from the
host. This is further evidence of the potency of this cell
population to contribute to scaffold vascularization. The
present study demonstrates the potential of preseeded
OECs in cell-based tissue engineering strategies as a
supplemental vascularization source, especially when
host-mediated vascularization proves insufficient by itself,
to fully integrate a biomaterial within the implantation
bed in an appropriate time frame and with a sufficient
vascular density.
Another finding in this study could help elucidate the
contribution of co-cultured osteoblasts to OEC-derived
vessel formation. Osteoblasts are known to produce
a number of signals, including paracrine factors such
as VEGF and structural components such as collagen
I, which exert a pro-angiogenic effect on the co-
cultured endothelial cells and enhance the formation of
vessel-like structures (Fuchs et al., 2009c; Unger et al.,
2007). Our histological evidence from serial sections
demonstrates co-localization of osteoblasts and OECs,
with the osteoblasts forming a surrounding layer on the
OEC-derived microvessels. These findings suggest that the
contribution of osteoblasts goes beyond only a paracrine
effect, and that the cell body of the osteoblasts may
serve a structural role in the formation of these new
vessels. Thus, osteoblasts may act as pericyte-like cells
within these co-cultures by contributing structural and
paracrine support to stabilize the endothelial-derived
vascular structures. Such a role may be similar to that
of an adventitial layer in normal vessel physiology, where
mural cells, including fibroblasts, smooth muscle cells
and other pericytes, provide structural support to vessels
and enhance angiogenesis (Gerhardt and Betscholtz,
2003; Shepro and Morel, 1993). A connection between
osteoblasts and pericytes is not without precedent.
However, in this respect most literature findings indicate
the potential of pericytes as pluripotent progenitors that
can undergo osteogenic differentiation (Brighton et al.,
1992; Doherty et al., 1998; Reilly et al., 1998). To our
knowledge, there is not a significant body of literature that
suggests the potential of osteoblasts to act in a pericyte-
like role. However, given the demonstrated similarities
in phenotypic expression (Reilly et al., 1998), perhaps
osteoblasts do have some capability to serve in this
pericyte-like role. This phenomenon may arise specifically
in co-cultures, where no other cell population exists
to support the endothelial cells in the vessel formation
process. Therefore, in co-cultures osteoblasts might be
committed to this role as the default cell source for
cell-based structural support of vessels. Nevertheless, the
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findings of this study, along with previous work, point to
a possible synergy between the pOBs and OECs, in which
pOBs may be able to provide both the chemical cues and
structural support needed for OEC to rapidly form vessels.
The finding that OECs rapidly vascularize SPCL scaf-
folds in co-culture with pOB after only 2 days of implan-
tation in vivo is promising for complex tissue engineering
strategies, in which a rapid scaffold vascularization is
desired. The rapid formation of anastomoses with the
host vasculature after only 48 h is quite exciting and
points to the potency of this cell source. The number of
OEC-derived vessels increased over the implantation time
with a density similar that of host-derived vessels. Further-
more, evidence is also provided for the multifunctional
role of pOBs in the co-culture, as a structural pericyte-like
support for the OEC-derived vessels was observed histo-
logically. These findings, together with previous in vitro
and in vivo studies by our group, demonstrate the poten-
tial of cellular crosstalk in co-cultures of endothelial cells
and osteoblasts to provide an effective cell-based approach
for tissue engineering.
5. Conclusion
The goal of our study was to establish the time
scale over which human-specific vessels arise from co-
cultures of osteoblasts and endothelial cells in vivo.
Additionally, this study further focused on the potential
roles osteoblasts may play in the formation of OEC-derived
microvessels. Our findings demonstrated that human-
specific vascular structures begin to form during in vitro
precultivation and that these structures anastomosed
with host vasculature within 48 h of implantation, as
there was evidence of human-derived vessels visibly
perfused with erythrocytes at this early time point. The
number of human cell-derived vessels increased with
time, irrespective of donor source, although the source
seemed to result in different cell potency. An additional
exciting finding was made histologically. While a pro-
angiogenic paracrine contribution from osteoblasts has
been previously established, we have demonstrated here
the potential of these cells to serve additionally as
structural vessel wall components, similar to that of
pericytes in normal vascular physiology. The findings
of this study further demonstrate the synergistic and
multifunctional role of osteoblasts in co-culture with
endothelial cells as an exciting strategy for cell-based
complex tissue engineering.
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